Results 71 to 80 of about 78,579 (196)
Formulation and characterization: Metoprolol succinate controlled release matrix tablets
Future Journal of Pharmaceuticals and Health SciencesMetoprolol succinate-controlled release matrix tablets were made utilizing the wet granulation process with various ratio of Hydroxypropyl methyl cellulose (HPMC K4M).
Alagusundaram M +4 more
semanticscholar +1 more source
Stable coronary heart disease treatment: focus on beta-adrenoblockers
Кардиоваскулярная терапия и профилактика, 2008 Stable angina treatment with a prolonged-action beta-adrenoblocker, metoprolol succinate, is discussed. Themedication is effective, metabolically neutral, well tolerated and could also be used in patients with comorbidities.
V. I. Makolkin
doaj
Future Journal of Pharmaceutical Sciences, 2018 Directly compressible (DC) co-processed excipient capable of providing nearly zero order release with improved functionality was developed without any chemical modification by employed various techniques such as physical mixing, high shear mixer ...
Prashant Kumar Choudhari +3 more
doaj +1 more source
Retracted: Effects of Metoprolol Succinate Combined with Entresto on Cardiac Function Indexes and Coagulation Function in Patients with Congestive Heart Failure. [PDF]
Comput Math Methods Med, 2023 Methods In Medicine CAM.
europepmc +1 more source
Development and Validation of SI/RS-UHPLC-PDA Method for Olmesartan Medoxomil and Metoprolol Succinate-Related Substance. [PDF]
Turk J Pharm Sci, 2023 Thakker N +3 more
europepmc +1 more source
Metoprolol succinate extended release/hydrochlorothiazide combination tablets
Vascular Health and Risk Management, 2007 James W Hainer, Jennifer SuggAstraZeneca LP, Wilmington, DE, USAAbstract: Lowering elevated blood pressure (BP) with drug therapy reduces the risk for catastrophic fatal and nonfatal cardiovascular events such as stroke and myocardial infarction.
James W Hainer, Jennifer Sugg
doaj
FarmaciaCoronary artery disease (CAD) with heart failure (HF) is a common clinical condition. This study aimed to assess the effects of sacubitril/valsartan combined with metoprolol succinate extended-release tablets on cardiac function (CF) in patients with CAD
Xuemei Liu
semanticscholar +1 more source
ClinicoEconomics and Outcomes Research, 2012 Varun Vaidya, Pranav PatelCollege of Pharmacy and Pharmaceutical Sciences, University of Toledo, Toledo, OH, USABackground: Metoprolol, a selective beta-1 blocker, is available in two different salt forms in the market – metoprolol succinate ...
Vaidya V, Patel P
doaj
Optimization of screw design for continuous wet granulation: A case study of metoprolol succinate ER tablets. [PDF]
Int J Pharm, 2022 Zidan A +4 more
europepmc +1 more source
Clinical review for general practiceBeta-blockers are currently one of the most prescribed drugs in various acute and chronic conditions due to wide range of indications and a large evidence base.
A. Skotnikov +3 more
semanticscholar +1 more source